C3i, is a full-service CDMO in Cell & Gene therapy, offering in-house services from, process development to commercial GMP manufacturing, Qc analytical development of tests and testing, biomarker development, immune monitoring, and CRO. We manufacture for Canada, US, and Europe
Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies.
Offer our clients a "one-stop-shop" solution for the development, translation, and commercialization of their products:
Our services
- GMP Manufacturing Unit for Cell and Gene therapies
- in-house testing Qc, Biomarker-Diagnostic and test development
- Clinical Research offering KOLs, protocol development, and Key patient access
- Investment & support for innovative companies
Company Details
- Employees
- 89
- Founded
- -
- Address
- Hôpital Maisonneuve-Rosemont, Pavillon Rachel Tourigny, 5415 Boulevard De L'assomption,canada
- Industry
- Biotechnology
- Website
- centrec3i.com
- Keywords
- Cancer Immunotherapy, Biomarkers, Diagnostics, cGMP Cell Manufacturing, Innovation, Commercialisation, Clinical Research, Networking, regenerative medicine, Stem cells, Oncology, Cell and Gene Therapy.
- HQ
- Montreal, Québec
C3i Questions
C3I's website is centrec3i.com
C3I's LinkedIn profile is https://ca.linkedin.com/company/c3icenter
C3I has
89 employees.
View email and phone details for 89
employees at C3I.
C3I's industry is
Biotechnology
C3I's top competitors are
Neurotech Pharmaceuticals, Inc.,
Excellthera,
Paraza Pharma Inc.,
Vvector Bio,
Omniabio,
Cellcan,
Ccrm,
Montréal Invivo,
Morphocell Technologies,
C3ihub, Iit Kanpur.
C3I's categories are Biotechnology
C3I's founding year is 2016
